High Circulating Tie-2 is Associated with Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer

Vascular endothelial growth factor (VEGF) is a central mediator of angiogenesis in breast cancer. Research in antiangiogenic cancer treatment has been marked by the development of the monoclonal antibody bevacizumab, which targets VEGF in many solid tumors. Since patients do not equally benefit from...

Full description

Saved in:
Bibliographic Details
Published in:Am J Clin Oncol
Main Authors: Makhoul, Issam, Griffin, Robert J., Siegel, Eric, Lee, Jeannette, Dhakal, Ishwori, Raj, Vinay, Jamshidi-Parsian, Azemat, Klimberg, Suzanne, Hutchins, Laura F., Kadlubar, Susan
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4490123/
https://ncbi.nlm.nih.gov/pubmed/24577164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000046
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items